Spots Global Cancer Trial Database for unknown primary tumors
Every month we try and update this database with for unknown primary tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. | NCT04276597 | Pulmonary Neuro... Pheochromocytom... Paraganglioma Thymus Carcinoi... Unknown Primary... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-DOTATOC | 18 Years - | Excel Diagnostics and Nuclear Oncology Center | |
| Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor | NCT00458315 | Unknown Primary... | Cisplatin Paclitaxel Gemcitabine Avastin (Bevaci... | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| PaCIFiC-CUP Classifies Cancer of Unknown Primary | NCT06140992 | Unknown Primary... DNA Methylation | 18 Years - 80 Years | Sun Yat-sen University | ||
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity | NCT04273061 | Breast Cancer Lung Cancer Gastrointestina... Genitourinary C... Gynecologic Can... Sarcoma Unknown Primary... Head and Neck C... Skin Cancer | Atezolizumab | 18 Years - | British Columbia Cancer Agency | |
| PaCIFiC-CUP Classifies Cancer of Unknown Primary | NCT06140992 | Unknown Primary... DNA Methylation | 18 Years - 80 Years | Sun Yat-sen University | ||
| HARE-40: HPV Anti-CD40 RNA vaccinE | NCT03418480 | Human Papilloma... Head and Neck N... Cervical Neopla... Penile Neoplasm... Unknown Primary... | BNT113 | 18 Years - | University of Southampton | |
| HARE-40: HPV Anti-CD40 RNA vaccinE | NCT03418480 | Human Papilloma... Head and Neck N... Cervical Neopla... Penile Neoplasm... Unknown Primary... | BNT113 | 18 Years - | University of Southampton | |
| Solving Riddles Through Sequencing | NCT05046444 | Leukemia Hematologic Mal... Rare Diseases Refractory Leuk... Refractory Lymp... Unknown Primary... | Next Generation... | 18 Years - 99 Years | Munich Leukemia Laboratory | |
| A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP) | NCT02607202 | Unknown Primary... | nab-paclitaxel Carboplatin Gemcitabine | 18 Years - | Fondazione del Piemonte per l'Oncologia | |
| Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor | NCT04100694 | NRG1 Fusion Pancreatic Canc... Non Small Cell ... Solid Tumor, Un... Prostate Cancer Head and Neck C... Colorectal Canc... Breast Cancer Cholangiocarcin... Renal Cell Carc... Unknown Primary... | MCLA-128 | 18 Years - | Merus N.V. | |
| Solving Riddles Through Sequencing | NCT05046444 | Leukemia Hematologic Mal... Rare Diseases Refractory Leuk... Refractory Lymp... Unknown Primary... | Next Generation... | 18 Years - 99 Years | Munich Leukemia Laboratory | |
| Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET. | NCT04276597 | Pulmonary Neuro... Pheochromocytom... Paraganglioma Thymus Carcinoi... Unknown Primary... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-DOTATOC | 18 Years - | Excel Diagnostics and Nuclear Oncology Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
